Back to Search
QUYNHANH LE, DOCTOR OF PHARMACY
DOCTOR OF PHARMACY
Pharmacist
NPI: 1386087922Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
RPH58081(CA)
Research & Publications (20)
Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03.
PMID 19667273·J Clin Oncol·2009
4-observational
Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222.
PMID 19364954·J Clin Oncol·2009
3-trial
Cost-effectiveness analysis of lapatinib in HER-2-positive advanced breast cancer.
PMID 19117341·Cancer·2009
8-other
Integrating biologically targeted therapy in head and neck squamous cell carcinomas.
PMID 19028346·Semin Radiat Oncol·2009
6-review
In vivo 1H magnetic resonance spectroscopy of lactate in patients with stage IV head and neck squamous cell carcinoma.
PMID 18258377·Int J Radiat Oncol Biol Phys·2008
8-other
Identifying and targeting hypoxia in head and neck cancer: a brief overview of current approaches.
PMID 17848296·Int J Radiat Oncol Biol Phys·2007
8-other
Distribution dynamics of the Tnt1 retrotransposon in tobacco.
PMID 17786479·Mol Genet Genomics·2007
8-other
Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas.
PMID 17707270·Int J Radiat Oncol Biol Phys·2007
8-other
Nasopharyngeal and oropharyngeal carcinomas: target delineation, therapy delivery and stereotactic boost procedures with intensity-modulated/ image-guided radiation therapy.
PMID 17641511·Front Radiat Ther Oncol·2007
6-review
Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors.
PMID 17409963·J Thorac Oncol·2006
3-trial
An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers.
PMID 16533775·Clin Cancer Res·2006
4-observational
Mature results from a randomized Phase II trial of cisplatin plus 5-fluorouracil and radiotherapy with or without tirapazamine in patients with resectable Stage IV head and neck squamous cell carcinomas.
PMID 16532436·Cancer·2006
3-trial
Galectin-1: a link between tumor hypoxia and tumor immune privilege.
PMID 16219933·J Clin Oncol·2005
7-preclinical
A comparison study of different PCR assays in measuring circulating plasma epstein-barr virus DNA levels in patients with nasopharyngeal carcinoma.
PMID 16115906·Clin Cancer Res·2005
4-observational
Nonsurgical therapy for stages I and II non-small cell lung cancer.
PMID 15833405·Hematol Oncol Clin North Am·2005
6-review
Phase I study of tirapazamine plus cisplatin/etoposide and concurrent thoracic radiotherapy in limited-stage small cell lung cancer (S0004): a Southwest Oncology Group study.
PMID 15328179·Clin Cancer Res·2004
3-trial
Prediction and quality assessment of transposon insertion display data.
PMID 14989085·Biotechniques·2004
7-preclinical
Therapeutic exploitation of the physiological and molecular genetic alterations in head and neck cancer.
PMID 14555497·Clin Cancer Res·2003
6-review
Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma.
PMID 12829140·Int J Radiat Oncol Biol Phys·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 14901 CENTRAL AVE
CHINO, CA 91710 - Phone
- (909) 597-1821
Quick Facts
- NPI
- 1386087922
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile